Claim your share of the $17M Revance/Crown merger securities class action settlement
Revance Therapeutics Merger $17M Securities SettlementInvestors who bought Revance securities between Feb. 29, 2024, and Feb. 6, 2025, may be eligible to claim a cash payment from a class action settlement.Loading the Elevenlabs Text to Spe.
- Settlement Amount
- $17 m
- Claim Deadline
- Aug 28, 2026
- Status
- Monitoring
Claim your share of the $17M Revance/Crown merger securities class action settlement
Summary
Revance Therapeutics Merger $17M Securities SettlementInvestors who bought Revance securities between Feb. 29, 2024, and Feb. 6, 2025, may be eligible to claim a cash payment from a class action settlement.Loading the Elevenlabs Text to Spe.
Key Details
- Settlement Amount: $17 m
- Deadline: 2026-08-28
- Status: Monitoring
Important Information
This record was generated from a public source and should be reviewed against official agency or settlement administrator materials.
Source
Case History
Update History
No material updates have been logged for this settlement yet. New deadlines, approvals, payment distributions, eligibility changes, and source notices will appear here.